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httpense.Abstract In thoracic imaging, mass means any pulmonary, pleural, or mediastinal lesion more
than 3 cm in diameter (without regard to contour, border, or density characteristics). Nodule means
rounded opacity, well or poorly deﬁned, measuring up to 3 cm in diameter. We report 4 rare cases –
presented as mass or nodular lesion in chest imaging.
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Introduction
Pulmonary hamartoma is a commonest benign lung lesion and
accounts for 3% of all lung tumours. It is a benign lesion com-
posed of cartilage, adipose tissue, ﬁbrous and myxoid connec-
tive tissue [1].
Case report
A 50 year old man presented with dry cough over 2 years and
one episode of breathlessness and chest pain. Routine haema-
tological examination, USG whole abdomen and Endoscopy
were normal. BAL ﬂuid cytological examination was negative
for malignancy. Chest X-ray and CT scan (Figs. 1 and 2) tho-
rax revealed a coin like lesion in the right lower lung. Biopsy of
the lung nodule could not be performed as patient’s relatives
refused for the procedure but right lower lobectomy wasis. Production and hosting by Elsevier B.V.
9.005
Figure 1 Chest X-ray PA view, coin lesion right lower lobe.
Figure 2 CT Thorax, well deﬁned pulmonary nodule.
Figure 3a Gross, right lower lobectomy specimen, whitish
globular mass subpleurally.
Figure 3b Cut section showing cartilaginous tissue.
Figure 4 Lobules of cartilages with cleft like spaces, (H&E stain
400·).
818 R. Saha et al.performed and histopathological examination of the specimen
diagnosed it as pulmonary hamartoma (Fig. 4).Discussion
The clinical importance of diagnosis of pulmonary hamartoma
is related to 2 things.
(1) It should be differentiated from malignant lesion.
(2) It may cause secondary symptoms due to compression.
The incidence of pulmonary hamartoma accounts to 6% of
solitary pulmonary lesion [7]. It usually is to be differentiated
from coin lesion. There is a strong correlation with age. They
are rarely seen in childhood and never at the time of birth [8].
They are most common in sixth and seven decade of life. Males
are mostly affected [1,3]. 53.8% of the patients show history of
heavy smoking [10]. Now it is considered as true neoplasm of
primitive bronchial mesenchymal tissue having capacity to dif-
ferentiate towards multiple mesenchymal components [1,2]. It
can be seen in all parts of lung but mostly in periphery and
rarely in hilar part [4,5]. Most patients are asymptomatic
and when incidentally found on chest X-ray examination [4]
only 1/3rd show symptoms [6]. Recurrence after resection is
uncommon [9]. Van den Bosch reported 2 cases of recurrence
in a series of 154 patients [2].
Figure 5b CT Thorax, nodular lesion in right thorax.
Figure 6 FNAC, mostly mature lymphocytes.
Unusual pulmonary lesions 819Our case was of a male nonsmoker patient aged 55 years
with a history of dry cough and breathlessness. Chest X-ray
and CT (Figs. 1 and 2) showed a coin like lesion in the right
lower lobe of lung situated subpleurally. Excision was done.
On gross examination there was a greyish white tumour having
cartilagenous area with ill deﬁned cleft like spaces (Figs. 3a
and 3b). On microscopic examination, there was a lobule of
cartilage with cleft like spaces lined by cuboidal epithelium
(Fig. 4). Diagnosis was done as pulmonary hamartoma with
no recurrence observed till date.
Pulmonary hamartoma is a benign lesion and represents
SPN (solitary pulmonary nodule) in imaging. Efﬁcacy of trans-
bronchial biopsy is of limited value in preoperative diagnosis.
Deﬁnitive treatment is achieved by surgical resection with min-
imum morbidity.
CASE 2: (Castleman disease)
Introduction
It is a rare benign and vascular lymphoproliferative disorder
which may present as nodal or extra nodal mass. It was ﬁrst
reported by Castleman in 1956 in a report of solitary mass in
the mediastinum [11].
Case-report
A 26 year old female presented with chest pain and breathless-
ness for 6 months. Routine haematological examination, USG
whole abdomen and Endoscopy were normal. Chest X-ray and
CT scan thorax revealed a nodular lesion in the right upper
lung. FNAC from the lung nodule was performed followed
by excision of the lesion. Gross and histopathological exami-
nation of the specimen was carried and it was diagnosed as
Castleman disease.
Discussion
Aetiology of Castleman disease is unknown. According to
some, viral infection may play a role. Commonest site is within
the thorax [12]. Pathogenesis is unknown but most people be-
lieve defective immunoregulation results in excessive B cell
proliferation and plasma cell inﬁltration in lymphoid organFigure 5a Chest X-ray, Nodular opacity, apical region of right
lung.[13]. There are 2 pathological types – hyaline vascular type
which is most common (90%) and plasma cell type which is
less common but clinically more aggressive. However, mixed
type may occur. Clinically they may be localised or dissemi-
nated. Localised ones are benign and disseminated lesions
are associated with symptoms like fever, splenomegaly and
leucocytosis [14].
Grossly, it is a single rounded mass (size varies from 1.5–
16 cm). Microscopically, they show a regressively transformedFigure 7 Lymphoid follicle with hyalinised germinal centre,
onion skin layering of mantle zone, and vascular inter follicular
area. Radially penetrating sclerotic vessels (lollipop appearance)
(H&E stain).
Figure 8 Whitish globular mass, cut surface whitish
homogeneou.
Figure 9 Chest X-ray PA view-mass, right middle and upper
lobe.
820 R. Saha et al.germinal centre surrounded by variably sized mantle zone
(onion skin layers) with prominent interfollicular vascularity
and absence of sinus. Germinal centre is devoid of lymphocyte
and consists of dendritic reticulum cell, endothelial cells with
hyalinisation and marked vascular proliferation [16]. The cap-
illaries penetrating the follicles at right angles give rise to ‘‘lol-
lipop appearance [15].’’
Recurrence is not expected [16,17].
In our case, the patient was a 26 year old female who pre-
sented with chest pain and breathlessness for 6 months. On
chest X-ray and CT thorax, a nodular opacity is seen in the
apical region of the right lung (Fig. 5a and 5b). When FNAC
was done, it showed the presence of lymphoid cells only
(Fig. 6). Excision of the mass was done. On gross examination,
it was a white globular mass with white homogenous cut sur-
face (Fig. 8). Microscopy showed the presence of lymphoid fol-
licle with hyalinised germinal centre, onion skin layering of
mantle zone, vascular interfollicular area, radially penetrating
sclerotic vessels (lollipop appearance) (Fig. 7). All the ﬁndings
support diagnosis of hyaline vascular type of Castleman dis-
ease. Recurrence is not seen till date.
CASE 3: (Inﬂammatory pseudotumour)
Introduction
It is a rare benign lung tumour of unknown aetiology occur-
ring in young patients. They are also known as plasma cell
granuloma, histiocytoma and ﬁbroxanthoma depending on
predominant cell type. Though benign, they have the capacity
to spread locally, grow rapidly and transform into sarcoma
[18]. Spontaneous regression even may occur after steroid ther-
apy. This case is reported because of rarity.
Case report
A 10 year old female presented with fever with occasional
cough and hemoptysis. General examination revealed club-
bing, SerumALP – 700 mg/dl, A: G – 1:3.5. Immunoproﬁle:
IgG – 3950 mg/dl (N 694 – 1618)IgA – 359 mg/dl (N 68–
378)IgM – 295 mg/dl (N 60–263) Urine for B.J. Protein:Negative. Bonemarrow aspiration revealed hypercellular mar-
row with M:E = 6:1. Erythropoisis: adequate and normoblas-
tic. Granulocytes are relatively increased with a slight increase
in lymphoid cells at places. Plasma cells – 8%. No parasites
were seen. All the ﬁndings were in favour of chronic disorder.
Debulking of the mass was done through the right posterior
intercostal space. Mass could not be removed totally due to
adherence to the adjacent structure.
Discussion
The various terminologies used have resulted in a great deal of
confusion regarding understanding the nature of the disease.
Microscopically, it consists of inﬂammatory cells with com-
plete maturity of the ﬁbroblastic element with no mitosis. It is
a nonneoplastic process characterised by unregulated growth
of inﬂammatory cells which may be due to derangement in
the metabolism with viral or immunological origin. Infection
may play a role [18].
Gross appearance shows a round well circumscribed nonen-
capsulated tumour mass in pulmonary parenchyma. Histopa-
thologically, it is a circumscribed mass composed of variable
mixture of collagen, benign mesenchymal cell, spindle myoﬁ-
broblast and ﬁbroblast with inﬂammatory cells like plasma
cell, macrophage, foam cell, giant cell, lymphocytes etc.
It is a benign lesion of childhood. Reported incidence is.
04% to 7% of lung masses [18]. There is no sex predilection
[25].
The symptomatology is cough, chest pain, dyspnoea, haem-
optysis, clubbing [18].
Most common radiological presentation is solitary well cir-
cumscribed round/oval pulmonary mass seen in 50% of pa-
tients [19]. Grossly, the tumour size varies from 5–30 cm
[21,22]. Age incidence according to Bahaduri and Leivo is 40
cases out of which 16 were child and 25 were adult [23]. Occa-
sionally it may cause obstructive pneumonia [24]. Central cav-
ity formation and hilar lymphadenopathy are very rare. No
pleural effusion has been reported till now [20].
It is a relatively uncommon lesion which is typically soli-
tary, peripheral sharply circumscribed lobulated mass. Most
patients are symptomatic at diagnosis and have prior history
of respiratory tract infection.
Figure 11 FNAC, mostly lymphocytes, plasmacytoid cells
(MGG STAIN 400·).
Figure 12 Spindle shaped ﬁbroblastic cells along with inﬂam-
matory inﬁltrate (H&E STAIN 400·).
Figure 10 CT mass right hemi thorax, focal calciﬁcation.
Unusual pulmonary lesions 821It should be differentiated from primary neoplasm, meta-
static tumour, hamartoma, chondroma, sclerosing haemangi-
oma and pulmonary granuloma.
Treatment of choice is surgical excision. Nonsurgical treat-
ment includes radiotherapy. Steroid therapy is indicated where
there is incomplete surgical removal, recurrence and when pa-
tient is unﬁt for surgery [18].In our case, the patient was a 10 year old female with fever
and cough with haemoptysis occasionally and with clubbing of
ﬁngers. X-ray and CT chest showed mass in the right, middle
and upper lobe with areas of calciﬁcation (Figs. 9 and 10).
Debulking of the mass was done through right posterior inter-
costal space but due to adherence total removal could not be
done. FNAC was done which showed lymphocytes and plas-
macytoid cells (Fig. 11). Microscopy showed ﬁbroblastic cells
with hyalinised collagen with inﬂammatory and plasma cells
(Fig. 12).
CASE 4: Large cell neuroendocrine tumour
Introduction
Large cell neuroendocrine tumour (LCNET) is categorised un-
der large cell tumour of the lung (WHO).
Case report
A 47 year old male habitual smoker presented with fever and
shortness of breath. Routine haematological examination
showed absolute eosinophil count-856/cumm, other parame-
ters-within normal limit. X-ray chest and CT thorax showed
mass in the lower lobe of the right lung. FNAC was done fol-
lowed by right lower lobectomy. Histopathological examina-
tion and IHC were in favour of LCNET.
Discussion
Travis et al. in 1991 were the ﬁrst to categorise LCNET as a
separate entity of pulmonary neuroendocrine tumour which
is different from typical carcinoid, atypical carcinoid and small
cell carcinoma [26]. These tumours have a cell size three times
than that of SCC, exhibit an organoid pattern, cellular palisad-
ing, high mitotic rate and a variably granular chromatin pat-
tern with absent or inconspicuous nucleolus and patches of
geographic necrosis [27].Figure 13 Chest ray PA view, mass lower lobe right lung.
Figure 14 CT, mass right hemi thorax.
Figure 15 Pleomorphic large cells, abundant cytoplasm, non small cell carcinoma of lung.
Figure 16 cut section showing tumour involving lung tissue. Figure 17 Microscopically, areas of necrosis and organoid
arrangement of tumour tissue(H&E –100·).
822 R. Saha et al.It is a very rare tumour with a low incidence rate. In a series
reported by Jiang et al. Ref. [28] of 766 patients with resected
primary lung cancer, only 22 were classiﬁed as LCNET
(2.87%). In another study, Takei et al. reported 87 cases out
of 2790 (3.1%) [29].
Smoking appears to be a primary cause of LCNET. Several
studies reported a strong correlation between LCNET and
habitual cigarette smoking [29–32]. Mean age of patientsranges from 62 to 68 years with median age of 65.8 years.
Males are the usual sufferers [29,33,35].
The tumour cells are shown to contain a neurosecretory
granule. On IHC, the tumour stains for neurone speciﬁc eno-
lase, carcinoembryonic antigen, chromogranin, Leu-7 and syn-
aptophysin [29]. These are also described by Wick et al. [37].
To identify a neuro endocrine tumour we need at least one
Unusual pulmonary lesions 823of the 3 markers – neural cell adhesion molecule, chromogra-
nin A and synaptophysin [29]. They most commonly present
as a peripheral tumour [30,34]. Symptoms like cough,Figure 18 Large polygonal cells with low N:C ratio, abundant
eosinophilic cytoplasm, coarse nuclear chromatin and prominent
nucleoli (H&E – 400·).
Figure 19 IHC staining, chromogranin positivity.haemoptysis, and pneumonia are less likely [35]. Paraneoplas-
tic syndrome is infrequent [29–31].
In our case, the patient was a 47 year old male, habitual
smoker who presented with fever and shortness of breath with
involvement of the lower lobe of the right lung. X-ray chest
and CT thorax showed mass in the lower lobe of the right lung
(Figs. 13 and 14). FNAC showed a pleomorphic large cell with
abundant cytoplasm and diagnosed as Non small cell carci-
noma (Fig. 15). Right lower lobectomy was done. Mass in-
volved whole of the cut surface (Fig. 16). Microscopy
showed a growth with organoid pattern and areas of necrosis
consisting of large cells with abundant cytoplasm (Figs. 17 and
18). IHC was done which showed chromogranin positivity
(Fig. 19).
The diagnosis of LCNEC needs to be done carefully because
there is a signiﬁcant overlap in the nuclear dimension between
LCNEC and SCC [36]. IHC should be done as conﬁrmatory.
The ﬁve year survival rate in resected LCNEC was only 35%
which was worse than the survival rate of 71.3% of LCC with
no evidence of neuroendocrine morphology. LCNEC is an
uncommon, aggressive neoplasm with poor prognosis. Because
of poorer prognosis, all LCC should be carefully searched for
the presence of occult neuro endocrine features.References
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